 | • レポートコード：GIR-23F3875 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Oral Live Cholera Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の経口生コレラワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 経口生コレラワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・Dukoral、Shanchol、Vaxchora、その他 アプリケーション別セグメントは次のように区分されます。 ・病院、科学研究、その他 世界の経口生コレラワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Valneva、PaxVax、Shantha Biotechnics Limited、Celldex Therapeutics、Merck、Ceva Asia 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 経口生コレラワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：Dukoral、Shanchol、Vaxchora、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、科学研究、その他 - 世界の経口生コレラワクチン市場規模・予測 - 世界の経口生コレラワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Valneva、PaxVax、Shantha Biotechnics Limited、Celldex Therapeutics、Merck、Ceva Asia ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：Dukoral、Shanchol、Vaxchora、その他 ・アプリケーション別分析2017年-2028年：病院、科学研究、その他 ・経口生コレラワクチンの北米市場分析 - 経口生コレラワクチンの北米市場：タイプ別市場規模2017年-2028年 - 経口生コレラワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・経口生コレラワクチンのヨーロッパ市場分析 - ：経口生コレラワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：経口生コレラワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・経口生コレラワクチンのアジア太平洋市場分析 - 経口生コレラワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 経口生コレラワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・経口生コレラワクチンの南米市場分析 - 経口生コレラワクチンの南米市場：タイプ別市場規模2017年-2028年 - 経口生コレラワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・経口生コレラワクチンの中東・アフリカ市場分析 - 経口生コレラワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 経口生コレラワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oral Live Cholera Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Live Cholera Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Oral Live Cholera Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dukoral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Live Cholera Vaccines include Valneva, PaxVax, Shantha Biotechnics Limited, Celldex Therapeutics, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Live Cholera Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dukoral
Shanchol
Vaxchora
Others
Market segment by Application can be divided into
Hospital
Scientific Research
Others
The key market players for global Oral Live Cholera Vaccines market are listed below:
Valneva
PaxVax
Shantha Biotechnics Limited
Celldex Therapeutics
Merck
Ceva Asia
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Live Cholera Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Live Cholera Vaccines, with price, sales, revenue and global market share of Oral Live Cholera Vaccines from 2019 to 2022.
Chapter 3, the Oral Live Cholera Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Live Cholera Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Live Cholera Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Live Cholera Vaccines.
Chapter 13, 14, and 15, to describe Oral Live Cholera Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oral Live Cholera Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Live Cholera Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Dukoral
1.2.3 Shanchol
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Live Cholera Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Oral Live Cholera Vaccines Market Size & Forecast
1.4.1 Global Oral Live Cholera Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Live Cholera Vaccines Sales in Volume (2017-2028)
1.4.3 Global Oral Live Cholera Vaccines Price (2017-2028)
1.5 Global Oral Live Cholera Vaccines Production Capacity Analysis
1.5.1 Global Oral Live Cholera Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Oral Live Cholera Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Live Cholera Vaccines Market Drivers
1.6.2 Oral Live Cholera Vaccines Market Restraints
1.6.3 Oral Live Cholera Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Valneva
2.1.1 Valneva Details
2.1.2 Valneva Major Business
2.1.3 Valneva Oral Live Cholera Vaccines Product and Services
2.1.4 Valneva Oral Live Cholera Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 PaxVax
2.2.1 PaxVax Details
2.2.2 PaxVax Major Business
2.2.3 PaxVax Oral Live Cholera Vaccines Product and Services
2.2.4 PaxVax Oral Live Cholera Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Shantha Biotechnics Limited
2.3.1 Shantha Biotechnics Limited Details
2.3.2 Shantha Biotechnics Limited Major Business
2.3.3 Shantha Biotechnics Limited Oral Live Cholera Vaccines Product and Services
2.3.4 Shantha Biotechnics Limited Oral Live Cholera Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Celldex Therapeutics
2.4.1 Celldex Therapeutics Details
2.4.2 Celldex Therapeutics Major Business
2.4.3 Celldex Therapeutics Oral Live Cholera Vaccines Product and Services
2.4.4 Celldex Therapeutics Oral Live Cholera Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Oral Live Cholera Vaccines Product and Services
2.5.4 Merck Oral Live Cholera Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Ceva Asia
2.6.1 Ceva Asia Details
2.6.2 Ceva Asia Major Business
2.6.3 Ceva Asia Oral Live Cholera Vaccines Product and Services
2.6.4 Ceva Asia Oral Live Cholera Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Live Cholera Vaccines Breakdown Data by Manufacturer
3.1 Global Oral Live Cholera Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Live Cholera Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Live Cholera Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Live Cholera Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Live Cholera Vaccines Manufacturer Market Share in 2021
3.5 Global Oral Live Cholera Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Live Cholera Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Live Cholera Vaccines Market Size by Region
4.1.1 Global Oral Live Cholera Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Live Cholera Vaccines Revenue by Region (2017-2028)
4.2 North America Oral Live Cholera Vaccines Revenue (2017-2028)
4.3 Europe Oral Live Cholera Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Oral Live Cholera Vaccines Revenue (2017-2028)
4.5 South America Oral Live Cholera Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Oral Live Cholera Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Live Cholera Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Oral Live Cholera Vaccines Revenue by Type (2017-2028)
5.3 Global Oral Live Cholera Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Live Cholera Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Oral Live Cholera Vaccines Revenue by Application (2017-2028)
6.3 Global Oral Live Cholera Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Live Cholera Vaccines Sales by Type (2017-2028)
7.2 North America Oral Live Cholera Vaccines Sales by Application (2017-2028)
7.3 North America Oral Live Cholera Vaccines Market Size by Country
7.3.1 North America Oral Live Cholera Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Live Cholera Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Live Cholera Vaccines Sales by Type (2017-2028)
8.2 Europe Oral Live Cholera Vaccines Sales by Application (2017-2028)
8.3 Europe Oral Live Cholera Vaccines Market Size by Country
8.3.1 Europe Oral Live Cholera Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Live Cholera Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Live Cholera Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Live Cholera Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Live Cholera Vaccines Market Size by Region
9.3.1 Asia-Pacific Oral Live Cholera Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Live Cholera Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Live Cholera Vaccines Sales by Type (2017-2028)
10.2 South America Oral Live Cholera Vaccines Sales by Application (2017-2028)
10.3 South America Oral Live Cholera Vaccines Market Size by Country
10.3.1 South America Oral Live Cholera Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Live Cholera Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Live Cholera Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Live Cholera Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Live Cholera Vaccines Market Size by Country
11.3.1 Middle East & Africa Oral Live Cholera Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Live Cholera Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Live Cholera Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Live Cholera Vaccines
12.3 Oral Live Cholera Vaccines Production Process
12.4 Oral Live Cholera Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Live Cholera Vaccines Typical Distributors
13.3 Oral Live Cholera Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Oral Live Cholera Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Live Cholera Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Valneva Basic Information, Manufacturing Base and Competitors
Table 4. Valneva Major Business
Table 5. Valneva Oral Live Cholera Vaccines Product and Services
Table 6. Valneva Oral Live Cholera Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. PaxVax Basic Information, Manufacturing Base and Competitors
Table 8. PaxVax Major Business
Table 9. PaxVax Oral Live Cholera Vaccines Product and Services
Table 10. PaxVax Oral Live Cholera Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Shantha Biotechnics Limited Basic Information, Manufacturing Base and Competitors
Table 12. Shantha Biotechnics Limited Major Business
Table 13. Shantha Biotechnics Limited Oral Live Cholera Vaccines Product and Services
Table 14. Shantha Biotechnics Limited Oral Live Cholera Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. Celldex Therapeutics Major Business
Table 17. Celldex Therapeutics Oral Live Cholera Vaccines Product and Services
Table 18. Celldex Therapeutics Oral Live Cholera Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Oral Live Cholera Vaccines Product and Services
Table 22. Merck Oral Live Cholera Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Ceva Asia Basic Information, Manufacturing Base and Competitors
Table 24. Ceva Asia Major Business
Table 25. Ceva Asia Oral Live Cholera Vaccines Product and Services
Table 26. Ceva Asia Oral Live Cholera Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Oral Live Cholera Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Oral Live Cholera Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Oral Live Cholera Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Oral Live Cholera Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Oral Live Cholera Vaccines Production Site of Key Manufacturer
Table 32. Oral Live Cholera Vaccines New Entrant and Capacity Expansion Plans
Table 33. Oral Live Cholera Vaccines Mergers & Acquisitions in the Past Five Years
Table 34. Global Oral Live Cholera Vaccines Sales by Region (2017-2022) & (K Units)
Table 35. Global Oral Live Cholera Vaccines Sales by Region (2023-2028) & (K Units)
Table 36. Global Oral Live Cholera Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Oral Live Cholera Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
Table 39. Global Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
Table 40. Global Oral Live Cholera Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Oral Live Cholera Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Oral Live Cholera Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 43. Global Oral Live Cholera Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 44. Global Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
Table 45. Global Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
Table 46. Global Oral Live Cholera Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Oral Live Cholera Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Oral Live Cholera Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Oral Live Cholera Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 50. North America Oral Live Cholera Vaccines Sales by Country (2017-2022) & (K Units)
Table 51. North America Oral Live Cholera Vaccines Sales by Country (2023-2028) & (K Units)
Table 52. North America Oral Live Cholera Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Oral Live Cholera Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. North America Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. North America Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. North America Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
Table 58. Europe Oral Live Cholera Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. Europe Oral Live Cholera Vaccines Sales by Country (2023-2028) & (K Units)
Table 60. Europe Oral Live Cholera Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Oral Live Cholera Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Europe Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
Table 64. Europe Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Europe Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Oral Live Cholera Vaccines Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Oral Live Cholera Vaccines Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Oral Live Cholera Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Oral Live Cholera Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
Table 74. South America Oral Live Cholera Vaccines Sales by Country (2017-2022) & (K Units)
Table 75. South America Oral Live Cholera Vaccines Sales by Country (2023-2028) & (K Units)
Table 76. South America Oral Live Cholera Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Oral Live Cholera Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. South America Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. South America Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
Table 81. South America Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Oral Live Cholera Vaccines Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Oral Live Cholera Vaccines Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Oral Live Cholera Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Oral Live Cholera Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. Oral Live Cholera Vaccines Raw Material
Table 91. Key Manufacturers of Oral Live Cholera Vaccines Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Oral Live Cholera Vaccines Typical Distributors
Table 95. Oral Live Cholera Vaccines Typical Customers
List of Figures
Figure 1. Oral Live Cholera Vaccines Picture
Figure 2. Global Oral Live Cholera Vaccines Revenue Market Share by Type in 2021
Figure 3. Dukoral
Figure 4. Shanchol
Figure 5. Vaxchora
Figure 6. Others
Figure 7. Global Oral Live Cholera Vaccines Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Global Oral Live Cholera Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Oral Live Cholera Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Oral Live Cholera Vaccines Sales (2017-2028) & (K Units)
Figure 14. Global Oral Live Cholera Vaccines Price (2017-2028) & (USD/Unit)
Figure 15. Global Oral Live Cholera Vaccines Production Capacity (2017-2028) & (K Units)
Figure 16. Global Oral Live Cholera Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Oral Live Cholera Vaccines Market Drivers
Figure 18. Oral Live Cholera Vaccines Market Restraints
Figure 19. Oral Live Cholera Vaccines Market Trends
Figure 20. Global Oral Live Cholera Vaccines Sales Market Share by Manufacturer in 2021
Figure 21. Global Oral Live Cholera Vaccines Revenue Market Share by Manufacturer in 2021
Figure 22. Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Oral Live Cholera Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Oral Live Cholera Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Oral Live Cholera Vaccines Sales Market Share by Region (2017-2028)
Figure 26. Global Oral Live Cholera Vaccines Revenue Market Share by Region (2017-2028)
Figure 27. North America Oral Live Cholera Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Europe Oral Live Cholera Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Oral Live Cholera Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. South America Oral Live Cholera Vaccines Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Oral Live Cholera Vaccines Revenue (2017-2028) & (USD Million)
Figure 32. Global Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
Figure 33. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
Figure 34. Global Oral Live Cholera Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
Figure 36. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
Figure 37. Global Oral Live Cholera Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
Figure 39. North America Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
Figure 40. North America Oral Live Cholera Vaccines Sales Market Share by Country (2017-2028)
Figure 41. North America Oral Live Cholera Vaccines Revenue Market Share by Country (2017-2028)
Figure 42. United States Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
Figure 46. Europe Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
Figure 47. Europe Oral Live Cholera Vaccines Sales Market Share by Country (2017-2028)
Figure 48. Europe Oral Live Cholera Vaccines Revenue Market Share by Country (2017-2028)
Figure 49. Germany Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Oral Live Cholera Vaccines Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Oral Live Cholera Vaccines Revenue Market Share by Region (2017-2028)
Figure 58. China Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
Figure 65. South America Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
Figure 66. South America Oral Live Cholera Vaccines Sales Market Share by Country (2017-2028)
Figure 67. South America Oral Live Cholera Vaccines Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Oral Live Cholera Vaccines Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Oral Live Cholera Vaccines Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Oral Live Cholera Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Oral Live Cholera Vaccines in 2021
Figure 79. Manufacturing Process Analysis of Oral Live Cholera Vaccines
Figure 80. Oral Live Cholera Vaccines Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source